Neuromyelitis optica spectrum disorder associated with cutaneous lupus and multidrug immunosuppressant hypersensitivity. [PDF]
Chu Han C +2 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus. [PDF]
Martins E +13 more
europepmc +1 more source
Evaluation of the applicability of the Cutaneous Lupus Erythematosus Area and Severity Index in Filipino cutaneous lupus erythematosus patients. [PDF]
Anarna GAR +5 more
europepmc +1 more source
Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review). [PDF]
Omar I, Alakhras A, Ahmad M, Mutwali S.
europepmc +1 more source
Guillain-Barré Syndrome, Subtype AMAN, Can Only Be Attributed to Lupus Erythematosus if All Infectious Causes Have Been Ruled Out [Response to Letter]. [PDF]
Sbitan L, Kanan M, Hasan HA, Hassan AM.
europepmc +1 more source
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I Antibodies. [PDF]
Di Berardino M +11 more
europepmc +1 more source
O36 HPV vaccination and cervical screening in SLE patients
Myles Lewis +9 more
doaj +1 more source
A Case of Longitudinal Extensive Transversal Myelitis in Patient With Neuromyelitis Optica Spectrum Disorder and Systemic Lupus Erythematosus. [PDF]
Pravdic N +7 more
europepmc +1 more source
TLR7 and TLR9 have overlapping but distinct roles in systemic lupus erythematosus and Sjögren's disease. [PDF]
Biswas S, Kramer JM.
europepmc +1 more source

